Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 3/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16300532 | 0.78 | KIF11 (0.43) | ALDH1A1ESR1ESR2CYP3A4MAPT | |
| SCHEMBL22788471 | 0.77 | ALDH1A1 (0.44) | ALDH1A1ALOX15ESR1ESR2CYP3A4 | |
| SCHEMBL1149712 | 0.76 | KCNN4 (0.59) | ALDH1A1ALOX15ESR1ESR2CYP3A4 | |
| Hydrochloric Acid SCHEMBL2810767 | 0.74 | KCNN4 (0.56) | ALDH1A1ALOX15ESR1ESR2CYP3A4 | |
| SCHEMBL14236873 | 0.74 | KCNN4 (0.44) | ALDH1A1ALOX15ESR1ESR2CYP3A4 | |
| SCHEMBL14306333 | 0.74 | KCNN4 (0.44) | ALDH1A1ALOX15ESR1ESR2CYP3A4 | |
| SCHEMBL29286845 | 0.72 | KCNN4 (0.48) | ALDH1A1ALOX15ESR1ESR2CYP3A4 | |
| SCHEMBL2038162 | 0.72 | KCNN4 (0.42) | ALDH1A1ALOX15ESR1ESR2CYP3A4 | |
| SCHEMBL27262221 | 0.72 | MAPT (0.47) | ALDH1A1ALOX15ESR1ESR2CYP3A4 | |
| Tert-Butylbenzene SCHEMBL309340 | 0.71 | LMNA (0.55) | ALDH1A1ALOX15ESR1ESR2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 479 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212340-A1 | CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY | Universität Zürich (CH) | 2023-07-06 | — | — | US | claimed |
| EP-2970538-B1 | POLYMERIZATION PROCESS PROTECTION MEANS | DUPONT ELECTRONICS INC (US) | 2021-10-20 | — | — | EP | claimed |
| WO-2021110991-A1 | CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY | Universität Zürich (CH) | 2021-06-10 | — | — | WO | claimed |
| EP-1054906-B2 | POLYMERIZATION PROCESS WITH LIVING CHARACTERISTICS AND POLYMERS MADE THEREFROM | COMMW SCIENT IND RES ORG (AU) | 2013-04-10 | — | — | EP | claimed |
| US-20100160574-A1 | Polymerisation Using Chain Transfer Agents | THE UNIVERSITY OF LEEDS (GB) | 2010-06-24 | — | — | US | claimed |
| US-20090215965-A1 | POLYMERISATION USING CHAIN TRANSFER AGENTS | THE UNIVERSITY OF LEEDS (GB) | 2009-08-27 | — | — | US | claimed |
| EP-1149075-B1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS | COMMW SCIENT IND RES ORG (AU) | 2008-12-31 | — | — | EP | claimed |
| WO-2008089518-A1 | POLYMER SYNTHESIS | POLYMERS CRC LTD (AU) | 2008-07-31 | — | — | WO | claimed |
| EP-1950232-A1 | Process for the preparation of graft copolymers by Reversible Addition Fragmentation Chain Transfer (RAFT) and Ring Opening Polymerisation (ROP) | Polymers Australia PTY Limited (AU) | 2008-07-30 | — | — | EP | claimed |
| US-7319083-B2 | Polymerized catalyst composition | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-01-15 | — | — | US | claimed |
| US-20040152591-A1 | Polymerized metallocene catalyst composition | EXXONMOBIL CHEMICAL PATENTS, INC. | 2004-08-05 | — | — | US | claimed |
| US-20040147391-A1 | Polymerized catalyst composition II | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-07-29 | — | — | US | claimed |
| US-20040024132-A1 | Polymerization process with living characteristics and polymers made therefrom | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2004-02-05 | — | — | US | claimed |
| US-6642318-B1 | Sulfur based chain transfer agents; widely compatible; free radical polymerization; producing low polydispersity and predictably specific architecture | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-11-04 | — | — | US | claimed |
| EP-1149075-A4 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | DU PONT (US) | 2003-10-22 | — | — | EP | claimed |
| US-6512081-B1 | Synthesis of dithioester chain transfer agents and use of bis(thioacyl) disulfides or dithioesters as chain transfer agents | E.I. DUPONT NEMOURS AND COMPANY | 2003-01-28 | — | — | US | claimed |
| EP-1149075-A1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-10-31 | — | — | EP | claimed |
| EP-1054906-A1 | POLYMERIZATION PROCESS WITH LIVING CHARACTERISTICS AND POLYMERS MADE THEREFROM | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-11-29 | — | — | EP | claimed |
| WO-1999031144-A1 | POLYMERIZATION PROCESS WITH LIVING CHARACTERISTICS AND POLYMERS MADE THEREFROM | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-06-24 | — | — | WO | claimed |
| WO-1999005099-A1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-02-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212340-A1 | CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY | REN, FLT4, FLT1 | ALDH1A1 1824/4885ALOX15 3341/4885ESR1 2483/4885 |
| US-20100160574-A1 | Polymerisation Using Chain Transfer Agents | TRRAP, TRMT1, IPO11 | ALDH1A1 2336/4885ALOX15 239/4885ESR1 3713/4885 |
| US-20090215965-A1 | POLYMERISATION USING CHAIN TRANSFER AGENTS | TRRAP, TRMT1, IPO11 | ALDH1A1 2336/4885ALOX15 239/4885ESR1 3713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.